Quebec’s IVF restrictions: Economics or ethics?
By MARINA ADSHADE,
The Globe and Mail
| 12. 12. 2014
Last week, Quebec Health Minister Gaétan Barrette tabled a bill
that, if passed, will prohibit women over the age of 42 from having
access to in vitro fertilization (IVF). While the purpose of the bill,
on the surface at least, is to lessen financial strain on the health
care system, this particular section of the bill will achieve a
different outcome; it will reduce the number of births to Quebec women
who rely on the use of donated eggs to conceive.
More Related to this Story
Quebec started providing medicare for
assistive reproductive technologies (ART) in 2010 in the hope of
achieving three objectives: reduce health care costs resulting from
multiple births; enable infertile couples to have children; and increase
the number of births in the province by between 1,000 and 1,500 per
year.
Despite claims that the program
has been widely abused, the number of births to Quebec woman has only
fallen since...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...